These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

728 related items for PubMed ID: 7791097

  • 21. Discriminative stimulus effects of butorphanol: influence of training dose on the substitution patterns produced by Mu, Kappa and Delta opioid agonists.
    Picker MJ, Benyas S, Horwitz JA, Thompson K, Mathewson C, Smith MA.
    J Pharmacol Exp Ther; 1996 Dec; 279(3):1130-41. PubMed ID: 8968334
    [Abstract] [Full Text] [Related]

  • 22. Repeated acquisition of behavioral chains in squirrel monkeys: comparisons of a mu, kappa and delta opioid agonist.
    Pakarinen ED, Woods JH, Moerschbaecher JM.
    J Pharmacol Exp Ther; 1995 Feb; 272(2):552-9. PubMed ID: 7853168
    [Abstract] [Full Text] [Related]

  • 23. A novel, potent and selective nonpeptidic delta opioid receptor agonist BW373U86.
    Chang KJ, Rigdon GC, Howard JL, McNutt RW.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):852-7. PubMed ID: 8246159
    [Abstract] [Full Text] [Related]

  • 24. Antagonism of delta(2)-opioid receptors by naltrindole-5'-isothiocyanate attenuates heroin self-administration but not antinociception in rats.
    Martin TJ, Kim SA, Cannon DG, Sizemore GM, Bian D, Porreca F, Smith JE.
    J Pharmacol Exp Ther; 2000 Sep; 294(3):975-82. PubMed ID: 10945849
    [Abstract] [Full Text] [Related]

  • 25. Convulsive effects of systemic administration of the delta opioid agonist BW373U86 in mice.
    Comer SD, Hoenicke EM, Sable AI, McNutt RW, Chang KJ, De Costa BR, Mosberg HI, Woods JH.
    J Pharmacol Exp Ther; 1993 Nov; 267(2):888-95. PubMed ID: 8246164
    [Abstract] [Full Text] [Related]

  • 26. Behavioral effects of the dopamine autoreceptor agonist PD 128483 alone and in combination with cocaine.
    Vanover KE, Woolverton WL.
    J Pharmacol Exp Ther; 1994 Sep; 270(3):1049-56. PubMed ID: 7932152
    [Abstract] [Full Text] [Related]

  • 27. Effects of the selective delta opioid agonist SNC80 on cocaine- and food-maintained responding in rhesus monkeys.
    Do Carmo GP, Mello NK, Rice KC, Folk JE, Negus SS.
    Eur J Pharmacol; 2006 Oct 10; 547(1-3):92-100. PubMed ID: 16934797
    [Abstract] [Full Text] [Related]

  • 28. Effects of estradiol on cocaine self-administration and cocaine discrimination by female rhesus monkeys.
    Mello NK, Negus SS, Knudson IM, Kelly M, Mendelson JH.
    Neuropsychopharmacology; 2008 Mar 10; 33(4):783-95. PubMed ID: 17507915
    [Abstract] [Full Text] [Related]

  • 29.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 30. Buprenorphine and naltrexone effects on cocaine self-administration by rhesus monkeys.
    Mello NK, Mendelson JH, Bree MP, Lukas SE.
    J Pharmacol Exp Ther; 1990 Sep 10; 254(3):926-39. PubMed ID: 2395121
    [Abstract] [Full Text] [Related]

  • 31. Discriminative stimulus effects of the nonpeptidic delta-opioid agonist SNC80 in rhesus monkeys.
    Brandt MR, Negus SS, Mello NK, Furness MS, Zhang X, Rice KC.
    J Pharmacol Exp Ther; 1999 Sep 10; 290(3):1157-64. PubMed ID: 10454490
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Evaluation of the reinforcing and discriminative stimulus effects of the N-methyl-D-aspartate competitive antagonist NPC 17742 in rhesus monkeys.
    Nicholson KL, Jones HE, Balster RL.
    Behav Pharmacol; 1997 Oct 10; 8(5):396-407. PubMed ID: 9832979
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35. 3,4-Methylenedioxymethamphetamine (MDMA, "ecstasy") and its stereoisomers as reinforcers in rhesus monkeys: serotonergic involvement.
    Fantegrossi WE, Ullrich T, Rice KC, Woods JH, Winger G.
    Psychopharmacology (Berl); 2002 Jun 10; 161(4):356-64. PubMed ID: 12073162
    [Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. The self-administration of MK-801 can depend upon drug-reinforcement history, and its discriminative stimulus properties are phencyclidine-like in rhesus monkeys.
    Beardsley PM, Hayes BA, Balster RL.
    J Pharmacol Exp Ther; 1990 Mar 10; 252(3):953-9. PubMed ID: 2181113
    [Abstract] [Full Text] [Related]

  • 39. Discriminative stimulus effects of naltrexone in morphine-treated rhesus monkeys.
    France CP, Woods JH.
    J Pharmacol Exp Ther; 1989 Sep 10; 250(3):937-43. PubMed ID: 2550623
    [Abstract] [Full Text] [Related]

  • 40. The delta-opioid receptor agonist SNC80 [(+)-4-[alpha(R)-alpha-[(2S,5R)-4-allyl-2,5-dimethyl-1-piperazinyl]-(3-methoxybenzyl)-N,N-diethylbenzamide] synergistically enhances the locomotor-activating effects of some psychomotor stimulants, but not direct dopamine agonists, in rats.
    Jutkiewicz EM, Baladi MG, Folk JE, Rice KC, Woods JH.
    J Pharmacol Exp Ther; 2008 Feb 10; 324(2):714-24. PubMed ID: 17986650
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 37.